TMRW has created a Robotic Process Automation (RPA) platform designed specifically for IVF that provides a complete RFID, cryo-temperature compatible digital chain of custody for fertility cells, including eggs and embryos. Its software automates roughly 17,000 daily environmental “health checks” to ensure the safety and security of stored cells. The platform is constantly vigilant and focused on reducing human error in cryostorage workflows. The company was co-founded by Joshua Abram, Alan Murray and Jeff Port, M.D., and is based in New York City. TMRW has expanded its corporate and scientific advisory boards alongside its financing, appointing Andrew Brooks, Ph.D. as Chair of its Scientific Advisory Board and adding Tara Comonte and Robbie Myers as independent corporate board directors. It intends to use the new capital to refine its technology and further expand its board and executive leadership team.

Total raised

$12M

Funding rounds

1

Latest round

Series A

Latest activity

May 2019